These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26743817)

  • 1. Hypotension Associated With Intravitreal Bevacizumab Therapy for Retinopathy of Prematurity.
    Wu LH; Yang YH; Lin CH; Lin YJ; Cheng CL
    Pediatrics; 2016 Feb; 137(2):e20152005. PubMed ID: 26743817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
    Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
    Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and Neuroimaging Changes After Bevacizumab for Retinopathy of Prematurity.
    Twitty G; Weiss M; Albayram MS; O'Mara K; Mowitz ME
    Pediatrics; 2020 Jan; 145(1):. PubMed ID: 31806670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal Bevacizumab for Zone II Retinopathy of Prematurity.
    Larrañaga-Fragoso P; Peralta J; Bravo-Ljubetic L; Pastora N; Abelairas-Gómez J
    J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):375-382. PubMed ID: 27537247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab for retinopathy of prematurity: Considerations for informed consent.
    Mireskandari K; Collins ME; Tehrani N
    Can J Ophthalmol; 2015 Dec; 50(6):409-12. PubMed ID: 26651298
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of Plasma Cytokine Profile Changes in Bevacizumab-Treated Retinopathy of Prematurity Infants.
    Kong L; Demny AB; Sajjad A; Bhatt AR; Devaraj S
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1649-54. PubMed ID: 27054517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab for Retinopathy of Prematurity: 2-Year Neurodevelopmental Follow-up.
    Zayek M; Parker K; Rydzewska M; Rifai A; Bhat R; Eyal F
    Am J Perinatol; 2021 Sep; 38(11):1158-1166. PubMed ID: 32446264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurodevelopment in patients with retinopathy of prematurity treated with intravitreal bevacizumab. Case series].
    Martínez-García SM; Hernández-Da Mota SE; Rubio-Rangel A; Rojas-Flores I; Vieyra-López ME; Martínez-Castellanos MA; Zavala-Martínez MT; Gómez García A
    Cir Cir; 2017; 85(6):478-484. PubMed ID: 28110900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental Outcomes in Infants with Retinopathy of Prematurity and Bevacizumab Treatment.
    Lien R; Yu MH; Hsu KH; Liao PJ; Chen YP; Lai CC; Wu WC
    PLoS One; 2016; 11(1):e0148019. PubMed ID: 26815000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractive outcome of intravitreal bevacizumab injection in comparison to spontaneous regression of retinopathy of prematurity (ROP).
    Etezad Razavi M; Shoeibi N; Hassanzadeh S; Kianmehr S; Bakhtiari E
    Strabismus; 2020 Mar; 28(1):49-54. PubMed ID: 31790628
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravitreal bevacizumab for retinopathy of prematurity as first line or rescue therapy with focal laser treatment. A case series.
    Dani C; Frosini S; Fortunato P; Bertini G; Pratesi S; Pollazzi L; Caputo R; La Torre A
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2194-7. PubMed ID: 22506618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral Vitreous Hemorrhage Following Bilateral Intravitreal Injections of Bevacizumab in an Infant With Retinopathy of Prematurity.
    Theophanous C; Schechet S; Rodriguez SH; Blair M
    Ophthalmic Surg Lasers Imaging Retina; 2018 Nov; 49(11):893-896. PubMed ID: 30457649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity.
    Morin J; Luu TM; Superstein R; Ospina LH; Lefebvre F; Simard MN; Shah V; Shah PS; Kelly EN;
    Pediatrics; 2016 Apr; 137(4):. PubMed ID: 27244705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lower dose of intravitreal bevacizumab effectively treats retinopathy of prematurity.
    Khodabande A; Niyousha MR; Roohipoor R
    J AAPOS; 2016 Dec; 20(6):490-492. PubMed ID: 27794470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Bevacizumab Alter Vascularization Potential in Retinopathy of Prematurity?
    Isaac M; Mireskandari K; Tehrani N
    Ophthalmology; 2016 Sep; 123(9):2042-3. PubMed ID: 27320519
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics of Severe Retinopathy of Prematurity in Infants with Birth Weight above 1500 Grams at a Referral Center in Turkey.
    Gunay M; Celik G; Tuten A; Karatekin G; Bardak H; Ovali F
    PLoS One; 2016; 11(8):e0161692. PubMed ID: 27548628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity.
    Arima M; Akiyama M; Fujiwara K; Mori Y; Inoue H; Seki E; Nakama T; Tsukamoto S; Ochiai M; Ohga S; Sonoda KH
    PLoS One; 2020; 15(3):e0230678. PubMed ID: 32196539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab.
    Snyder LL; Garcia-Gonzalez JM; Shapiro MJ; Blair MP
    Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):280-3. PubMed ID: 26985803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual adverse choroidal reaction to intravitreal bevacizumab in aggressive posterior retinopathy of prematurity: the Indian Twin Cities ROP screening (ITCROPS) data base report number 7.
    Chhablani J; Rani PK; Balakrishnan D; Jalali S
    Semin Ophthalmol; 2014 Jul; 29(4):222-5. PubMed ID: 24117452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity.
    Quiroz-Mercado H; Martinez-Castellanos MA; Hernandez-Rojas ML; Salazar-Teran N; Chan RV
    Retina; 2008 Mar; 28(3 Suppl):S19-25. PubMed ID: 18317339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.